Analyst Update: Aerie Pharmaceuticals Inc, Bristol-Myers Squibb Co, and Clovis Oncology Inc

Analysts are weighing in on Aerie Pharmaceuticals Inc (AERI), Bristol-Myers Squibb Co (BMY), and Clovis Oncology Inc (CLVS)

Sep 20, 2016 at 2:04 PM
facebook X logo linkedin


Analysts are weighing in on biotech stocks Aerie Pharmaceuticals Inc (NASDAQ:AERI)Bristol-Myers Squibb Co (NYSE:BMY), and Clovis Oncology Inc (NASDAQ:CLVS). Here's a quick roundup of today's brokerage notes on AERI, BMY, and CLVS.

  • AERI is up 13.2% to $38.62 -- and fresh off yet another all-time high of $38.75 -- after H.C. Wainwright initiated coverage on the stock with an upbeat "buy" rating and a $66 price target, representing a nearly 71% premium over the shares' current levels. Aerie Pharmaceuticals Inc surged higher last week on a pair of fundamental scores, and short sellers are likely sweating. These pessimistic bets account for more than one-third of AERI's total float. At the stock's typical daily volumes, it would take almost three weeks for bears to cover all the shorted shares.
  • BMY has added 1.5% to $55.93, after the firm announced the European Medicines Agency (EMA) validated a type II variation application for Opdivo, a treatment for an advanced form of bladder cancer. The news has overshadowed a price-target cut to $70 from $75 at Citigroup. Bristol-Myers Squibb Co hit an annual low of $55.02 on Monday, continuing a downward slide that begin with an early August bear gap. Analysts have low expectations for the stock at the moment, too. Of the 17 brokerage firms providing coverage, 12 rate BMY a "hold" or a "strong sell."
  • CLVS is 1.9% higher at $31.50, after a price-target hike to $38 from $30 at SunTrust Robinson. The shares have finally been gaining some traction in recent weeks, but are still down a painful 70% year-over-year. More than half of Clovis Oncology Inc's available float is wrapped up in short interest, but options traders have been busy picking up calls at a faster-than-usual rate. Specifically, CLVS' 10-day call/put volume ratio on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX) sits at a top-heavy 16.71 -- higher than 82% of all readings in the past year.
Don't miss the market's next move! Sign up now for Schaeffer's Midday Market Check
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI